TipRanks
Go Ultimate55% OFF

Lycia Therapeutics, Inc. (LYCA) Ownership - Who Owns Lycia Therapeutics, Inc.?

Lycia Therapeutics, Inc. (LYCA) Ownership Overview

  • 14.29% Insiders
  • 85.71% Public Companies and Individual Investors

The ownership structure of Lycia Therapeutics, Inc. (LYCA) stock is a mix of institutional, retail, and individual investors. , 14.29% is owned by Insiders, and 85.71% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Oct 29, 2026Venrock Healthcare Capital Partners Iii, L.p.$644,711
Oct 26, 2026Venrock Healthcare Capital Partners Iii, L.p.$37,653,863

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

LYCA top shareholders
Holder# of SharesType% HoldingValue
Venrock Healthcare Capital Partners Iii, L.p.6,850,237Insider11.88%180,846,257
Versant Ventures Vii Gp, L.p.1,393,882Insider2.42%36,798,485

FAQ

What percentage of Lycia Therapeutics, Inc. (LYCA) stock is held by retail investors?
According to the latest TipRanks data, approximately 85.71% of Lycia Therapeutics, Inc. (LYCA) stock is held by public companies and individual investors.
Who owns the most shares of Lycia Therapeutics, Inc. (LYCA)?
Venrock Healthcare Capital Partners III, L.P. owns the most shares of Lycia Therapeutics, Inc. (LYCA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.